Skip to main content
. 2024 Jan 17;37(2):234–247. doi: 10.1021/acs.chemrestox.3c00255

Figure 1.

Figure 1

Pathways to the activation of the carcinogens in this study. (A) Aflatoxin B1 (AFB1); (B) aristolochic acid I (AAI); (C) 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).